Skip to content

Journal of the American Association of Nurse Practitioners

ISSN 2327-6886

4 papers in the library · publishing 2016-2026

Papers

Sort Most recent Most cited

Learning to take up space: A mindfulness reflection

Journal of the American Association of Nurse Practitioners September 22, 2026 Erin Doan, Lori Gray, Heather Noble

ABSTRACT: The attitudes of Mindfulness-Based Stress Reduction, nonjudging, patience, trust, beginner's mind, nonstriving, and letting go, offer valuable guidance for today's strained health care environments. These principles gradually informed the development of a Nurse Practitioner (NP) and Physician Associate (PA) Fellowship program designed to support NPs and PAs transitioning into complex...

The “microdosing” dilemma: Balancing patient anecdotes with clinical safety amid GLP-1 compounding restrictions

Journal of the American Association of Nurse Practitioners May 26, 2026 Nicole Trainer

ABSTRACT: The recent resolution of semaglutide and tirzepatide shortages by the US Food and Drug Administration (FDA) has fundamentally altered the regulatory landscape for compounded obesity medications. Despite recent federal pricing agreements to reduce GLP-1 costs, ongoing affordability barriers continue to drive patient desperation, fueling a shift toward unsupervised strategies such as...

DOI: 10.1097/jxx.0000000000001296 (opens in new tab) Patient safety Economic shortage Nurse practitioners Risk management +10

Cannabis update: Anxiety disorders and post-traumatic stress disorder.

Journal of the American Association of Nurse Practitioners May 1, 2023 Amy L Haycraft

The development of anxiety disorders and post-traumatic stress disorder (PTSD) is complex. Both delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are of potential therapeutic use. Evidence suggests that cannabis has a beneficial effect on neural circuitry involved in fear regulation. In the United States, cannabis is considered either medical or recreational and can contain pure THC or...

The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in U.S. military veterans.

Journal of the American Association of Nurse Practitioners December 15, 2016 Annamarie Breen, Kory Blankley, Julie Fine

Background and purpose: Nightmares associated with posttraumatic stress disorder (PTSD) are a hallmark symptom among U.S. military veterans who have seen combat. Management of combat-related nightmares can be difficult and current pharmacologic options are limited and tend to have adverse side effects. The aim of this review is to explore recent literature regarding the efficacy of prazosin for...